Top Pharmaceutical Contract Development and Manufacturing Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Pharmaceutical Contract Development and Manufacturing Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Pharmaceutical Contract Development and Manufacturing industry players.

Pharmaceutical Contract Development and Manufacturing Market Competitive Landscape

To improve their market position, players in the industry are concentrating on agreements, partnerships, collaborations, acquisitions, and other tactics. Pharma firms must provide more and better new pharmaceuticals to combat the diseases to which the human body is susceptible in order to combat the rising number of new diseases.

Top Players in Pharmaceutical Contract Development and Manufacturing Market

  • Cambrex Corporation 
  • Samsung Biologics Co., Ltd. 
  • Siegfried Holdings AG 
  • FUJIFILM Diosynth Biotechnologies 
  • Aenova Group 
  • Wuxi Biologics, Inc. 
  • Aurobindo Pharma, Ltd. 
  • Vetter Pharma International GmbH 
  • Thermo Fisher Scientific, Inc. 
  • Catalent, Inc 
  • Recipharm AB 
  • Almac Group 
  • Lonza Group Ltd. 
  • Piramal Enterprises Limited 
  • Fabbrica Italiana Sintetici S.p.A. 
  • Fareva SA 
  • C.H. Boehringer Sohn AG & Co. KG. 
  • Jubilant Pharmova Limited 
  • Curia Global, Inc. 
  • Delpharm Holdings 

Pharmaceutical Contract Development and Manufacturing Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Pharmaceutical Contract Development and Manufacturing Market size was valued at USD 122.2 billion in 2023 and is poised to grow from USD 130.63 billion in 2024 to USD 222.78 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032). 

To improve their market position, players in the industry are concentrating on agreements, partnerships, collaborations, acquisitions, and other tactics. Pharma firms must provide more and better new pharmaceuticals to combat the diseases to which the human body is susceptible in order to combat the rising number of new diseases. 'Cambrex Corporation ', 'Samsung Biologics Co., Ltd. ', 'Siegfried Holdings AG ', 'FUJIFILM Diosynth Biotechnologies ', 'Aenova Group ', 'Wuxi Biologics, Inc. ', 'Aurobindo Pharma, Ltd. ', 'Vetter Pharma International GmbH ', 'Thermo Fisher Scientific, Inc. ', 'Catalent, Inc ', 'Recipharm AB ', 'Almac Group ', 'Lonza Group Ltd. ', 'Piramal Enterprises Limited ', 'Fabbrica Italiana Sintetici S.p.A. ', 'Fareva SA ', 'C.H. Boehringer Sohn AG & Co. KG. ', 'Jubilant Pharmova Limited ', 'Curia Global, Inc. ', 'Delpharm Holdings '

The market is being driven by the advantages of outsourcing, namely the savings in time and money. To increase their share of outsourcing revenue, market players frequently spend on infrastructure, staff, and technology.

With the rise in cancer incidence and the creation of safe and efficient medications thanks to technical advancements, the market for oncology treatments has expanded quickly. Because of the growing demand for potent, focused medicines and the ability of compounds to be more selective towards the target of interest to reduce dosing frequencies, there is an increasing interest in highly potent New Chemical Entities (NCEs).

The pharmaceutical contract development and manufacturing market is anticipated to be dominated by North America in 2022, followed by Europe and Asia-Pacific. The substantial share of this region is primarily linked to expanding generic medicine and biologics demand, CDMO consolidation, rising need for biosimilars due to patent expiry, and rising outsourcing costs. Furthermore, the focus on pharmaceutical and biotechnology research by organisations has made the contract manufacturing business in North America extremely competitive.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Pharmaceutical Contract Manufacturing Market
Buy Now GET FREE SAMPLE
Pharmaceutical Manufacturing Market
Buy Now GET FREE SAMPLE
Biopharmaceuticals Contract Manufacturing Market
Buy Now GET FREE SAMPLE
Pharmaceutical Logistics Market
Buy Now GET FREE SAMPLE
Medical Device Contract Manufacturing Market
Buy Now GET FREE SAMPLE
Pharmaceuticals Market
Buy Now GET FREE SAMPLE
Pharmaceutical Packaging Market
Buy Now GET FREE SAMPLE
Pharmaceutical Processing and Packaging Equipment Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Pharmaceutical Contract Development and Manufacturing Market
Pharmaceutical Contract Development and Manufacturing Market

Report ID: SQMIG35J2034

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE